Advertisement

Topics

miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EMT axis

17:33 EDT 25 Oct 2017 | Nature Publishing

Original Article: miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EMT axis

NEXT ARTICLE

More From BioPortfolio on "miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EMT axis"

Quick Search
Advertisement